What the team is known for
One of the finest IP and patent litigation practices in the world, routinely coordinating complex cross-border disputes. Deep and longstanding involvement in life sciences, with expertise in regulatory and compliance matters and commercial transactions in the sector. Also advises on IP-led M&A and investment deals.
Strengths
A client says: "Bird & Bird have good expertise in the biotech space."
Another interviewee says the lawyers provide "good practical advice andlook at the bigger picture."
According to one client, the team "provides geographical breadth and uniform excellence throughout," while on the technical aspects, "they are excellent and know the nuts and bolts of life sciences."
Work highlights
Advised Ablynx on the development and marketing of nanobodies for medicinal applications, as well as related multi-jurisdictional litigation to consider a certain aspect of the Recast Brussels Regulation.
Notable practitioners
Mark Hilton is a first port of call for numerous leading pharmaceutical companies. He is best known for his patent litigation work in the life sciences sector, and also advises on IP licensing transactions and interactions with regulatory agencies.
Morag Macdonald has profound sector expertise handling complex patent and IP disputes for global pharmaceutical and biotech innovators. She frequently acts on matters with cross-border and Europe-wide implications.
Neil Jenkins is an expert in patent litigation and has acted for many leading innovators in pharmaceuticals, biotech and medical devices. He has experience representing both innovator and generic companies in relation to biosimilar drugs.
Sally Shorthose advises sector-leading multinationals on collaboration agreements, licensing deals and regulatory requirements in different European jurisdictions.
"Sally Shorthose is extremely knowledgeable and can provide legal advice suited to the business goals of the companies in their respective sectors." "She is practical and knowledgeable." 